- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 99-113 of
231 results
1020 Exhibit: US Provisional Application 61421,470
Document
IPR2022-00853, No. 1020 Exhibit - US Provisional Application 61421,470 (P.T.A.B. Apr. 12, 2022)
|
|
Cite Document
1024 Exhibit: SIFT webpage Internet Archive Decl and Exhibit
Document
IPR2022-00853, No. 1024 Exhibit - SIFT webpage Internet Archive Decl and Exhibit (P.T.A.B. Apr. 12, 2022)
|
|
Cite Document
2019 Exhibit: Stephan A Grupp et al, T Cells Engineered With A Chimeric Antigen R...
Document
IPR2022-00853, No. 2019 Exhibit - Stephan A Grupp et al, T Cells Engineered With A Chimeric Antigen Receptor CAR Targeting CD 19 CTL0l 9 Produce Significant In Vivo Proliferation, Complete...
|
|
Cite Document
2017 Exhibit: David L Porter et al, Chimeric Antigen Receptor Modified T Cells Direc...
Document
IPR2022-00853, No. 2017 Exhibit - David L Porter et al, Chimeric Antigen Receptor Modified T Cells Directed Against CD 19 CTL0l 9 cells Have Long Term Persistence And Induce Durable Respo...
|
|
Cite Document
2016 Exhibit: Jennifer Couzin Frankel, Breakthrough of the Year 2013 Cancer Imm...
Document
IPR2022-00853, No. 2016 Exhibit - Jennifer Couzin Frankel, Breakthrough of the Year 2013 Cancer Immunotherapy, 342 SCI 1432 2013 (P.T.A.B. Jul. 19, 2022)
|
|
Cite Document
2026 Exhibit: Information Disclosure Statement Initialed by Examiner Feb 22, 2016...
Document
IPR2022-00853, No. 2026 Exhibit - Information Disclosure Statement Initialed by Examiner Feb 22, 2016, US Patent Application No 14,996,953 (P.T.A.B. Jul. 19, 2022)
|
|
Cite Document
2042 Exhibit: US Patent No 7,402,431
Document
IPR2022-00853, No. 2042 Exhibit - US Patent No 7,402,431 (P.T.A.B. Jul. 19, 2022)
|
|
Cite Document
2038 Exhibit: Michael H Kershaw et al, A Phase I Study on Adoptive Immunotherap...
Document
IPR2022-00853, No. 2038 Exhibit - Michael H Kershaw et al, A Phase I Study on Adoptive Immunotherapy Using Gene Modified T Cells for Ovarian Cancer, 12 CLINICAL CANCER RSCH 6106 20...
|
|
Cite Document
2002 Exhibit: Denise Grady, An Immune System Trained to Kill Cancer, NY TIMES S...
Document
IPR2022-00853, No. 2002 Exhibit - Denise Grady, An Immune System Trained to Kill Cancer, NY TIMES Sept 12, 2011, httpswwwnytimescom20110913health13genehtml (P.T.A.B. Jul. 19, 2022...
|
|
Cite Document
2039 Exhibit: Cor HJ Lamers et al, Treatment of Metastatic Renal Cell Carcinoma W...
Document
IPR2022-00853, No. 2039 Exhibit - Cor HJ Lamers et al, Treatment of Metastatic Renal Cell Carcinoma With Autologous T Lymphocytes Genetically Retargeted Against Carbonic Anhydrase IX Fi...
|
|
Cite Document
2012 Exhibit: Renier J Brentjens et al, Safety and persistence of adoptively transfe...
Document
IPR2022-00853, No. 2012 Exhibit - Renier J Brentjens et al, Safety and persistence of adoptively transferred autologous CD19 targeted T cells in patients with relapsed or chemotherapy refracto...
|
|
Cite Document
2014 Exhibit: Renier J Brentjens et al, A Phase I Trial for the Treatment of Chemo re...
Document
IPR2022-00853, No. 2014 Exhibit - Renier J Brentjens et al, A Phase I Trial for the Treatment of Chemo refractory Chronic Lymphocytic Leukemia with CD19 Targeted Autologous T Cells, 16 MOL...
|
|
Cite Document
2001 Exhibit: Jason Fagone, Has Carl June Found a Key to Fighting Cancer, PHILA...
Document
IPR2022-00853, No. 2001 Exhibit - Jason Fagone, Has Carl June Found a Key to Fighting Cancer, PHILA MAG Aug 1, 2013 (P.T.A.B. Jul. 19, 2022)
|
|
Cite Document
2025 Exhibit: Agilent Presents Thought Leader Award to Drs Carl H June and Micha...
Document
IPR2022-00853, No. 2025 Exhibit - Agilent Presents Thought Leader Award to Drs Carl H June and Michael Milone, AGILENT TECHS INC Nov 17, 2020, httpswwwagilentcomaboutnewsroompres...
|
|
Cite Document
2035 Exhibit: Grazyna Lipowska Bhalla, Targeted immunotherapy of cancer with CA...
Document
IPR2022-00853, No. 2035 Exhibit - Grazyna Lipowska Bhalla, Targeted immunotherapy of cancer with CAR T cells achievements and challenges, 61 CANCER IMMUNOLOGY, IMMUNOTHERAP...
|
|
Cite Document
